🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Fermenta Biotech Limited FERMENTA NSE

· India
https://fermentabiotech.com
Company Profile ↓
₹463.60
+45.60% 1Y
P/E19.01
P/B3.16
52W High₹463.60
52W Low₹281.00
Book Value₹140.98
EPS (TTM)₹24.39

Company Overview

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed, and rodenticides; pharmaceutical ingredients comprising phenyramidol and silicon dry powder; nutritional premixes; and enzymes for use in oleochemicals, fine chemicals, active pharmaceutical ingredients, food and fragrances, leather, and biodiesel industries. In addition, it engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 17.2%, reflecting efficient use of shareholder capital.

Consistent Profit Growth

Net profit has compounded at 47.1% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 12.6% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.28.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹525.00 Cr (+12.2% YoY); net profit ₹70.00 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +12.2%, earnings -7.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 12.6%, profit CAGR 47.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:12.62%
1 Year:12.18%

Compounded Profit Growth

5 Years:47.14%
1 Year:-7.89%

Stock Price Performance

1 Year:+45.60%
6 Months:-
3 Months:-
1 Month:+42.03%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 100% of range
₹281.00 ₹463.60
Trend Signals
  • Price vs 50-DMAAbove
  • RSI (14)76.60 · Overbought
Price Performance
1M+42.03%
1Y+45.60%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 12.6% over 5 years.
  • Profit CAGR of 47.1% over 5 years.
  • Generates positive free cash flow.

CONS

  • RSI at 77 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
19.01
Industry PE
-
Forward P/E est.
20.64
PEG Ratio
-
Book Value
₹140.98
Price to Book
3.16
P/S
-
EV/EBITDA
13.51
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
12.62%
Profit 5Y
47.14%
Revenue (YoY)
12.18%
Earnings (YoY)
-7.89%

Profitability & Returns

ROCE
-
ROE
17.24%
ROA
10.80%
Profit Margin
13.33%
Op Margin
14.86%
Gross Margin
63.47%
EPS (Latest Qtr)
₹6.52
EPS (TTM)
₹24.39

Balance Sheet & Liquidity

Debt/Equity
0.28
Quick Ratio
0.76
Current Ratio
1.86
Debt
₹113.00 Cr
Total Assets
₹648.00 Cr
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
73.48%
Chg in Prom Hold
9.40%
FII / Inst Holding
0.00%
Chg in FII Hold
-0.02%

Financial Snapshot

Enterprise Value
₹1,348.67 Cr
Total Revenue (TTM)
₹525.00 Cr
EBITDA
₹100.00 Cr
Free Cash Flow
₹63.00 Cr
Operating Cash Flow
₹93.00 Cr
Shares Outstanding
-
Gross Margin
63.47%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 105.00 Cr82.00 Cr57.00 Cr99.00 Cr97.00 Cr78.00 Cr95.00 Cr156.00 Cr140.00 Cr136.00 Cr130.00 Cr137.00 Cr122.00 Cr
Operating Expenses 86.00 Cr72.00 Cr71.00 Cr74.00 Cr92.00 Cr77.00 Cr76.00 Cr103.00 Cr103.00 Cr108.00 Cr104.00 Cr112.00 Cr102.00 Cr
Operating Income 13.00 Cr5.00 Cr-20.00 Cr19.00 Cr-1.00 Cr-5.00 Cr13.00 Cr47.00 Cr31.00 Cr22.00 Cr22.00 Cr20.00 Cr15.00 Cr
EBITDA 19.00 Cr11.00 Cr-14.00 Cr25.00 Cr5.00 Cr1.00 Cr19.00 Cr53.00 Cr37.00 Cr28.00 Cr27.00 Cr25.00 Cr20.00 Cr
Interest Expense 6.00 Cr5.00 Cr4.00 Cr5.00 Cr3.00 Cr3.00 Cr4.00 Cr4.00 Cr3.00 Cr3.00 Cr3.00 Cr3.00 Cr3.00 Cr
Pretax Income -1.00 Cr2.00 Cr-29.00 Cr16.00 Cr1.00 Cr-6.00 Cr12.00 Cr45.00 Cr32.00 Cr28.00 Cr24.00 Cr17.00 Cr26.00 Cr
Tax Provision -3.73 Cr0-06.08 Cr8.85 Cr-072.00 L7.20 Cr-1.28 Cr6.44 Cr6.00 Cr5.27 Cr7.54 Cr
Net Income -5.00 Cr2.00 Cr-29.00 Cr10.00 Cr-7.00 Cr-6.00 Cr11.00 Cr38.00 Cr33.00 Cr22.00 Cr18.00 Cr12.00 Cr19.00 Cr
Diluted EPS -1.400.62-9.703.35-2.36-1.983.8712.5411.687.426.144.316.52

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 142.00 Cr155.00 Cr164.00 Cr302.00 Cr403.00 Cr292.00 Cr376.00 Cr397.00 Cr349.00 Cr335.00 Cr468.00 Cr525.00 Cr
Operating Expenses 126.00 Cr134.00 Cr152.00 Cr209.00 Cr248.00 Cr225.00 Cr293.00 Cr335.00 Cr330.00 Cr307.00 Cr352.00 Cr426.00 Cr
Operating Income 7.00 Cr13.00 Cr2.00 Cr81.00 Cr144.00 Cr51.00 Cr63.00 Cr36.00 Cr-10.00 Cr3.00 Cr91.00 Cr78.00 Cr
EBITDA 16.00 Cr21.00 Cr12.00 Cr93.00 Cr156.00 Cr66.00 Cr83.00 Cr62.00 Cr18.00 Cr28.00 Cr115.00 Cr100.00 Cr
Interest Expense 4.00 Cr6.00 Cr10.00 Cr14.00 Cr21.00 Cr20.00 Cr19.00 Cr18.00 Cr21.00 Cr17.00 Cr15.00 Cr12.00 Cr
Pretax Income 3.00 Cr7.00 Cr-6.00 Cr76.00 Cr129.00 Cr43.00 Cr52.00 Cr27.00 Cr-51.00 Cr-10.00 Cr83.00 Cr96.00 Cr
Tax Provision 2.01 Cr4.27 Cr-2.94 Cr21.28 Cr10.32 Cr-15.91 Cr9.36 Cr11.88 Cr-2.04 Cr-14.30 Cr6.64 Cr25.92 Cr
Net Income 1.00 Cr2.00 Cr-9.00 Cr46.00 Cr117.00 Cr60.00 Cr43.00 Cr15.00 Cr-53.00 Cr-24.00 Cr76.00 Cr70.00 Cr
Diluted EPS 0.17-0.41-4.1412.2142.7120.2315.465.25-17.36-7.8426.1224.39

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 262.00 Cr288.00 Cr307.00 Cr385.00 Cr551.00 Cr614.00 Cr687.00 Cr707.00 Cr637.00 Cr548.00 Cr614.00 Cr648.00 Cr
Total Equity 131.00 Cr130.00 Cr144.00 Cr124.00 Cr251.00 Cr309.00 Cr360.00 Cr372.00 Cr315.00 Cr288.00 Cr363.00 Cr406.00 Cr
Total Debt 71.00 Cr89.00 Cr87.00 Cr173.00 Cr209.00 Cr224.00 Cr232.00 Cr239.00 Cr220.00 Cr139.00 Cr115.00 Cr113.00 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 15.00 Cr4.00 Cr2.00 Cr59.00 Cr90.00 Cr34.00 Cr63.00 Cr43.00 Cr116.00 Cr105.00 Cr41.00 Cr93.00 Cr
Investing Cash Flow -18.00 Cr-13.00 Cr7.00 Cr-101.00 Cr-97.00 Cr-44.00 Cr-41.00 Cr-26.00 Cr-55.00 Cr-16.00 Cr-0-43.00 Cr
Financing Cash Flow 1.00 Cr10.00 Cr-12.00 Cr89.00 Cr12.00 Cr-47.00 Cr-1.00 Cr-22.00 Cr-41.00 Cr-91.00 Cr-51.00 Cr-42.00 Cr
Capital Expenditure -35.00 Cr-29.00 Cr-19.00 Cr-17.00 Cr-35.00 Cr-68.00 Cr-56.00 Cr-37.00 Cr-40.00 Cr-19.00 Cr-3.00 Cr-30.00 Cr
Free Cash Flow -20.00 Cr-25.00 Cr-17.00 Cr42.00 Cr55.00 Cr-34.00 Cr7.00 Cr6.00 Cr76.00 Cr86.00 Cr38.00 Cr63.00 Cr
Net Change in Cash -2.00 Cr1.00 Cr-4.00 Cr47.00 Cr6.00 Cr-57.00 Cr21.00 Cr-4.00 Cr19.00 Cr-1.00 Cr-10.00 Cr8.00 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ------------
Operating Margin % 4.9%8.4%1.2%26.8%35.7%17.5%16.8%9.1%-2.9%0.9%19.4%14.9%
Net Margin % 0.7%1.3%-5.5%15.2%29.0%20.5%11.4%3.8%-15.2%-7.2%16.2%13.3%
ROE % 0.8%1.5%-6.2%37.1%46.6%19.4%11.9%4.0%-16.8%-8.3%20.9%17.2%
ROCE % ------------

Shareholding Pattern

Insiders
73.48%
Institutions
0.00%
Public Float
0.01%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for FERMENTA

Google News Mon, 20 Apr 2026

FERMENTA Stock Price and Chart — NSE:FERMENTA - TradingView

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1uWEpQcTFwRzlUTTNQQ0xSWm01RjRGM1A0RnQ1UjY5Mkg1TUJ6ZXcxNzkxX2hWU0Nmc215WVpRZ1Uyanhqdk5acFpqeEhOdXlBQ29IMTNFMGRDemNrYWc?oc=5" target="_blank">FERMENTA Stock Price and Chart — NSE:FER…

Google News Mon, 06 Jul 2026

Stocks to Watch Today: Supriya Lifescience, Rubicon Research, Fortis Healthcare, Fermenta Biotech - BusinessLine

<a href="https://news.google.com/rss/articles/CBMiggJBVV95cUxOYlpYMVdEQlZocy1GLUpxa2E1ZnBuSlJna2ZJbWJTVFNRdTM1a2lFYm9QSzdxZEF3UnluRUNwYUREYTVvaUowY3hveEc3clotal9MSjhGVV9uUlhJeHhkMkJOcXdtTldFeU5ldVZiYUFMbnRjUEZKSlhaUEhBekJKa2hiaW9DdHB3ek1VTH…

Google News Wed, 17 Jun 2026

Fermenta Biotech Applies for NSE Listing to Enable Trading of 2.91 Crore Equity Shares - Sahi

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZ2FTSjhUOWM4TWdQMkVmODdSS2RWTHFlaEY4YXh4TkpRZC1XRENNUWdkbF8ydWUtV1RtTXYtZ04zMkRBZWVadzd5VmdwYVhxdmgwYm9iZnE0c05mbUNOZHRYM0ExdWZmSm05eUxBUFBTMC13TlkyWkpVNkM1TXNxMGFuUWgwcXdqeVBSSX…

Google News Wed, 24 Jun 2026

Fermenta Biotech Ltd Surges 3.48% - Business Standard

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOWWNiLU5hX1NoSXAzcUhfell0b2MtaWNuaFVSamVUVDJMX1BibDR3aEc5YjJTZEkyN1Z6RzZBQmc4VTVVNUZFRVFSa3RrUHRUUzNpbXYzcTBoREFGOVJpRm1EYUMwazZqX25WeE1zUGhybXBhc2tpTkI2LWVCT3EyYUFTU2NyVGotLUFnZ1…

Google News Mon, 15 Jun 2026

Fermenta Biotech | Stock Share Price Live - MarketSmith India

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE96RkJFeU1RSE9udnU1NFFKUzY1aVY2QlRkdzZMcUNseW1DOHViSWg1aFFxcHQ5ZFVscVUyN1pSU1pJRjhncG9IeXl4eUh1VDFaZGhNajl0SWxqT01Sc3V5NldLWGdDOGx3VnVrOERrQlRubm9xTmlBeg?oc=5" target="_blank">Ferme…

Google News Sat, 27 Jun 2026

Fermenta Biotech - Concurrent Gainers: 10 smallcap stocks that gain for 5 days in a row - The Economic Times

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcUlQdFdCNGpEXzlUUnA0VU9ibU9hcjJlQUptTXVhdlIwY2FRWG9mN050dVdsZldCc1cyS1BvTXZFY1RQNUN6Yk00U0cwT0l5eno4OTRoYjBieEI4QkZaRThGbVZZZVd0OXhqSjN1YUlmSFJCOW1XS1JpbnhNVms0djBsWGNidGNXZHU1VE…

FERMENTA — Frequently Asked Questions

What is the current share price of Fermenta Biotech Limited (FERMENTA)?

As of 2026-07-15 09:52 IST, Fermenta Biotech Limited (FERMENTA) trades at ₹463.60 on NSE. Its 52-week range is ₹281.00 to ₹463.60.

What is the P/E ratio of FERMENTA?

FERMENTA trades at a trailing price-to-earnings (P/E) ratio of 19.01. Its price-to-book (P/B) ratio is 3.16.

What is the return on equity (ROE) of FERMENTA?

FERMENTA has a return on equity (ROE) of 17.24%.

Is FERMENTA a good stock to buy?

This page provides a data-driven analysis of Fermenta Biotech Limited (FERMENTA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space